Results 21 to 30 of about 107,212 (296)
Both a pericardial effusion and a failing myocardium can produce the roentgen appearance of a large, smoothly dilated heart which shows little evidence of pulsations. The correct diagnosis is often suggested by the appearance of the hilar vessels which are usually obscured by the cardiac shadow that is enlarged by a pericardial effusion, and not by the
openaire +2 more sources
A positive cytology result in pericardial fluid is the gold standard for recognition of malignant pericardial effusion. Unfortunately, in 30–50% of patients with malignant pericardial effusion cytological examination of the pericardial fluid is negative.
M. Szturmowicz +9 more
doaj +1 more source
Nivolumab is an immune checkpoint inhibitor that is used to treat various advanced cancers, including metastatic non-small cell lung cancer (NSCLC). Nivolumab treatment has different side effects.
Zhihui Cai, Yuan Yao
doaj +1 more source
Diagnosis and management of pericardial effusion
Pericardial effusion is a common pathology in clinical practice. The etiology of pericardial effusion is diverse, from infectious diseases, malignancies, autoimmune diseases, chronic renal failure, to drug-related or after an invasive cardiac ...
Maria Manea +3 more
doaj +1 more source
Introduction: The presence of mild to moderate pericardial effusion after cardiac surgery is common and oral medical therapy is usually able to treat it. Larger effusions are less frequent and surgical intervention is usually necessary.
Luis Alberto Oliveira Dallan (12682768) +5 more
core +1 more source
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi +21 more
wiley +1 more source
Presumed hydrochlorothiazide-associated immunologic-hypersensitivity-induced pericardial effusion
A 50-year-old Caucasian female presented for a second opinion regarding a newly diagnosed pericardial effusion. Seven months previously, hydrochlorothiazide was introduced into her pharmacologic regimen to aid in the management of her hypertension.
Michael J Chaskes, Mark B Chaskes
doaj +1 more source
Pericardial Involvement in Severe COVID-19 Patients
Background and Objectives: SARS-CoV-2 has an extensive tissue tropism due to its ability to attach to the surfaces of cells through different receptors, leading to systemic complications.
Mihai Lazar +10 more
doaj +1 more source
Background: Pericardial effusion may culminate in cardiac tamponade which could be fatal. This study aims to describe the prevalence of cardiac tamponade, with the etiology, and outcome of childhood pericardial effusion at Aminu Kano Teaching Hospital ...
Igoche David Peter +2 more
doaj +1 more source
Pericardial effusion under nivolumab: case-reports and review of the literature
Background Nivolumab, a programmed death-1 (PD-1) inhibitor, is an immune checkpoint inhibitor particularly used in the treatment of malignant melanoma, non-small cell lung cancer and renal cell carcinoma. Immune-related adverse events are frequent under
Saade Anastasia +7 more
doaj +1 more source

